FGFR2 and breast carcinoma: We identified FGFR2 to be significant via both expression- and splicing-based TWAS approaches and tissue with the max PIP was cultured fibroblasts (PIP = 1), indicating FGFR2 likely causally impacts breast cancer risk through its expression in fibroblasts.